DRKS00027028已完成不适用
miR-AD: miRNAs for early detection of Alzheimer's disease. - miR-AD Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 243
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 55 Years 至 85 Years（—）
- 性别
- All
入选标准
- •Group 1) 120 patients with SCI, MCI or mild dementia (MMSE >20) with confirmed molecular trait Alzheimer's disease (MCI-AD).
- •Group 2) 120 patients with SCI, MCI or mild dementia (MMSE >20) with exclusion of molecular trait Alzheimer (MCI-other).
- •Additional inclusion criteria are:
- •- Neuropsychiatric examination (CERAD, CDR) at time of blood draw confirming SCI, MCI or Mild Dementia (e.g., MMSE > 20).
排除标准
- •- not able to provide consent
- •- advanced dementia MMSE < 20
- •- cerebral microangiopathy Fazekas grade III
- •- cerebral hemorrhage or cerebral ischemia less than 3 months ago
- •- known infectious diseases (HIV, HCV, HBV)
- •- known cancer in the last 5 years
研究者
相似试验
已完成
不适用
Early diagnosis of Alzheimer's disease using resting-state fMRIAlzheimer'd diseaseJPRN-UMIN000022642Tokyo Metropolitan Institute of Gerontology40
尚未招募
不适用
Minimally invasive detection of early Alzheimer*s disease pathology at the eye clinic using blood tests and eye-scans: the BeyeOMARKER studyAlzheimer's diseasedementiaNL-OMON56662Amsterdam UMC700
尚未招募
不适用
Improving the early diagnosis of Alzheimer*s disease and other dementiasmental disorder1004225810012272dementiaNL-OMON29838Academisch Medisch Centrum320
已完成
不适用
Study on Diagnosis of early Alzheimer's disease-JapaMild Cognitive ImpairmentJPRN-C000000297Department of Brain Science and Molecular Imaging National Institute for Longevity Sciences National Center for Geriatrics and Gerontology150
Enrolling By Invitation
不适用
BioFINDER-Brown: Examination of Alzheimer's Disease BiomarkersAlzheimer DiseaseMild Cognitive ImpairmentDementiaNCT05457998Butler Hospital200